Involvement of Patient Organisations in Research and Development of Orphan Drugs for Rare Diseases in Europe

Publisher： Karger

E-ISSN： 1661-8777|3|5|237-243

ISSN： 1661-8769

Source： Molecular Syndromology, Vol.3, Iss.5, 2012-09, pp. : 237-243

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

RE(ACT)® International Congress on Research on Rare and Orphan Diseases

By  

Molecular Syndromology, Vol. 2, Iss. 6, 2012-04 ,pp. : 262-288

Karger

Access to resources Recommend Favorite

EUROPLAN: A Project to Support the Development of National Plans on Rare Diseases in Europe

By  

Public Health Genomics, Vol. 16, Iss. 6, 2014-02 ,pp. : 278-287

Karger

Access to resources Recommend Favorite

RE(ACT)2014 Rare Diseases. 2nd International Congress on Research of Rare and Orphan Diseases. 5th to 8th March 2014, Gehry Building, Novartis Campus, Basel: Abstracts

By  

Molecular Syndromology, Vol. 5, Iss. 2, 2014-02 ,pp. : 87-99

Karger

Access to resources Recommend Favorite

Orphan Drugs and Orphan Tests in the USA

By  

Public Health Genomics, Vol. 7, Iss. 4, 2005-01 ,pp. : 169-172

Karger

Access to resources Recommend Favorite

RE(ACT) Congress 9-12 March 2016, Barcelona. 3rd International Congress on Research of Rare and Orphan Diseases. 9th to 12th March 2016. Crowne Plaza Barcelona - Fira Center, Barcelona, Spain: Abstracts

By  

Molecular Syndromology, Vol. 6, Iss. 6, 2016-0 ,pp. : 304-335

Karger

Access to resources Recommend Favorite